Pelvic Organ Preservation in Non-muscle-invasive Bladder Cancer: Less Is More.


Journal

European urology focus
ISSN: 2405-4569
Titre abrégé: Eur Urol Focus
Pays: Netherlands
ID NLM: 101665661

Informations de publication

Date de publication:
07 2023
Historique:
received: 08 02 2023
revised: 20 03 2023
accepted: 21 04 2023
medline: 31 7 2023
pubmed: 5 5 2023
entrez: 4 5 2023
Statut: ppublish

Résumé

Radical cystectomy (RC) is a treatment option for high-risk non-muscle-invasive bladder cancer (NMIBC) but is associated with high morbidity and a negative impact on quality of life. Reproductive or pelvic organ-sparing cystectomy (ROSC) techniques have emerged as a potential strategy to mitigate some potential effects of standard RC. Here we discuss current knowledge regarding oncological, functional, and sexual function outcomes associated with ROSC and their applicability in NMIBC. These outcomes can be used to make informed clinical decisions regarding cystectomy technique in appropriately staged and selected patients with NMIBC. PATIENT SUMMARY: We reviewed results for bladder cancer control, urinary function, and sexual function after removal of the bladder with and without techniques to spare reproductive or pelvic organs. We found evidence of better sexual function outcomes with a sparing approach without compromise of cancer control. Further studies are needed to assess urinary function and pelvic floor-related outcomes.

Identifiants

pubmed: 37142535
pii: S2405-4569(23)00103-7
doi: 10.1016/j.euf.2023.04.006
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

571-574

Informations de copyright

Copyright © 2023 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Auteurs

Anne Faulk (A)

School of Medicine, LSU Health Science Center-New Orleans, New Orleans, LA, USA.

Svetlana Avulova (S)

Department of Urology, Albany Medical Center, Albany, NY, USA.

Kelly K Bree (KK)

Department of Urology, MD Anderson Cancer Center, Houston, TX, USA.

Janet Baak-Kukreja (J)

Division of Urology, University of Colorado, Aurora, CO, USA.

Mary E Westerman (ME)

Department of Urology, LSU Health Science Center-New Orleans, New Orleans, LA, USA; Department of Surgery, East Jefferson General Hospital, Metairie, LA, USA. Electronic address: mweste@lsuhsc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH